An interventional study of Kinesiotaping and Mulligan Mobilization Technique in Subacromial Impingement Syndrome, Musculoskeletal Diseases and Musculoskeletal Injury, sponsored by Banu BAYAR. Completed at 1 site in Turkey. Open to participants aged 35 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-12-21.
Sponsored by Banu BAYAR · Not applicable, Interventional, and Treatment
A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS).
Subacromial impingement syndrome (SIS) is characterized by shoulder pain that is exacerbated with especially arm elevation or overhead physical activities.
493 studies on the registry are indexed under Musculoskeletal Pain; 113 are open to participants now.
This study's enrollment of 60 is below the median of 69 across 346 interventional studies indexed under Musculoskeletal Pain.
Browse Musculoskeletal Pain studies →Banu BAYAR is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Control group
Experimental group
Other: Kinesiotaping
Experimental group (2)
Other: Mulligan Mobilization Technique
KT was applied.
MMT was applied
Change of pain severity
Via VAS.
Time frame: Baseline- after 2 weeks (after treatment)
Change of Range of Motion
Via goniometer.
Time frame: Baseline- after 2 weeks (after treatment)
Change of Functionality
Via SPADI.
Time frame: Baseline- after 2 weeks (after treatment)
Change of Sleep Quality
Via VAS.
Time frame: Baseline- after 2 weeks (after treatment)
Change of Satisfaction of Life
Via SWLS.
Time frame: Baseline- after 2 weeks (after treatment)
Change of Satisfaction of Treatment
Via VAs.
Time frame: Baseline- after 2 weeks (after treatment)
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Banu BAYAR